Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

TScan Therapeutics (TCRX)

TScan Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TCRX
DateTimeSourceHeadlineSymbolCompany
14/06/202421:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRXTScan Therapeutics Inc
14/06/202421:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRXTScan Therapeutics Inc
14/06/202421:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TCRXTScan Therapeutics Inc
14/06/202412:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
14/06/202412:00GlobeNewswire Inc.TScan Therapeutics Announces Updates to its Board of DirectorsNASDAQ:TCRXTScan Therapeutics Inc
30/05/202412:00GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare ConferenceNASDAQ:TCRXTScan Therapeutics Inc
29/05/202412:00GlobeNewswire Inc.TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme MalignanciesNASDAQ:TCRXTScan Therapeutics Inc
13/05/202412:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRXTScan Therapeutics Inc
13/05/202412:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
13/05/202412:00GlobeNewswire Inc.TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TCRXTScan Therapeutics Inc
09/05/202412:00GlobeNewswire Inc.TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid TumorsNASDAQ:TCRXTScan Therapeutics Inc
24/04/202421:05GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual MeetingNASDAQ:TCRXTScan Therapeutics Inc
24/04/202416:03GlobeNewswire Inc.TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional SharesNASDAQ:TCRXTScan Therapeutics Inc
22/04/202422:01GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual MeetingNASDAQ:TCRXTScan Therapeutics Inc
19/04/202415:05GlobeNewswire Inc.TScan Therapeutics Announces Closing of Upsized Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
17/04/202405:30GlobeNewswire Inc.TScan Therapeutics Announces Pricing of Upsized $150 Million Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
16/04/202421:25GlobeNewswire Inc.TScan Therapeutics Announces Launch of $125 Million Proposed Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
16/04/202421:01GlobeNewswire Inc.TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term PrioritiesNASDAQ:TCRXTScan Therapeutics Inc
08/04/202413:00GlobeNewswire Inc.TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical OfficerNASDAQ:TCRXTScan Therapeutics Inc
02/04/202412:00GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:TCRXTScan Therapeutics Inc
06/03/202421:11Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TCRXTScan Therapeutics Inc
06/03/202421:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TCRXTScan Therapeutics Inc
06/03/202412:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TCRXTScan Therapeutics Inc
06/03/202412:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
14/02/202421:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRXTScan Therapeutics Inc
29/01/202412:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
11/12/202313:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
07/12/202312:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
09/11/202312:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRXTScan Therapeutics Inc
09/11/202312:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TCRX